We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WWW:NYSEWolverine World Wide, Inc. Analysis

Data as of 2026-05-11 - not real-time

$16.70

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Wolverine World Wide (WWW) is trading at $16.70, which sits below its 20‑day SMA of 17.42 and just above the identified support of $16.04, indicating limited upside in the immediate term. The technical picture is mixed: RSI at 45 suggests neutral momentum, while a bearish MACD histogram reinforces short‑term pressure. On the valuation side, the stock is priced beneath its DCF‑derived fair value of $17.61 and carries a forward PE of 9.99, signaling an undervalued stance relative to earnings expectations. Fundamentals remain solid with a 4.6% revenue growth rate, a robust ROE of 27.1%, and a dividend yield of 2.4% supported by a modest 35% payout ratio. However, the balance sheet is leveraged – debt‑to‑equity exceeds 180% – and the beta of 1.68 plus a 30‑day volatility near 37% point to heightened market sensitivity. Recent material news highlights a strategic partnership with Microsoft Azure to embed predictive behavioral AI across the Merrell and Saucony brands, and new leadership hires aimed at accelerating product innovation in the Work Group, both of which could sharpen marketing efficiency and drive top‑line growth.
Given the blend of undervalued pricing, solid cash generation, and forward‑looking AI initiatives, the medium‑ to long‑term outlook is positive, but investors should monitor the near‑term technical weakness and the company’s high leverage. The consensus analyst view remains a “Buy” with a median target of $23.5, implying substantial upside if the company can translate its digital initiatives into sales while managing debt levels.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with limited upside
  • Bearish MACD signal
  • Upcoming AI rollout may not yet be reflected in price

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to DCF and forward PE
  • Strategic AI partnership expected to boost marketing efficiency
  • Strong ROE and sustainable dividend yield

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Diversified brand portfolio with durable consumer demand
  • Long‑term growth potential from digital transformation initiatives
  • Dividend sustainability and attractive yield

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin5.11%
P/E Ratio14.6
ROE27.11%
ROA5.66%
Debt/Equity180.10
P/B Ratio3.3
Op. Cash Flow$140.0M
Free Cash Flow$123.3M

Technical Analysis

TrendNeutral
RSI45.1
Support$16.04
Resistance$19.19
MA 20$17.42
MA 50$16.91
MA 200$20.98
MACDBearish
VolumeStable
Fear & Greed Index90.73

Valuation

Fair Value$17.61
Target Price$23.20
Upside/Downside38.92%
GradeUndervalued
TypeBlend
Dividend Yield2.40%

Risk Assessment

Beta1.69
Volatility36.98%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.